Clinical Trial Update: Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic Mix [EARLY_Phase 1]

View source ↗

Summary

An early-phase, proof-of-concept pharmacology trial evaluating a biologic mix designed for HIV antigen presentation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIV antigen presentation therapeutic biologic mix

Snippet

Sponsor: Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair | Conditions: HIV Infections | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING